View in EDS HTML Full Text PDF Full Text

Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study*.

Saved in:
Bibliographic Details
Title: Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study*.
Authors: Robak, Tadeusz1 robaktad@csk.umed.lodz.pl, Huang, Huiqiang2, Jin, Jie3, Zhu, Jun4, Liu, Ting5, Samoilova, Olga6, Pylypenko, Halyna7, Verhoef, Gregor8, Siritanaratkul, Noppadol9, Osmanov, Evgenii10, Pereira, Juliana11, Mayer, Jiri12, Hong, Xiaonan13, Okamoto, Rumiko14, Pei, Lixia15, Rooney, Brendan16, van de Velde, Helgi17, Cavalli, Franco18
Source: Leukemia & Lymphoma. Jan2019, Vol. 60 Issue 1, p172-179. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2017.1321750